Adicet Bio Q3 Results Scheduled for November 11
Adicet Bio is scheduled to report Q3 results on November 11. Revenue is estimated at zero, with EPS anticipated at negative 1.58.
Related stories
NHPC Q2 consolidated revenue from operations at 44.83 billion rupees
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
MGE Energy Reports Q3 2026 Operating Revenue of $190.4 Million
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
US Equity Futures Rise Pre-Bell as Traders Assess Midterm Election Results
US equity futures rose before the bell as traders assessed the implications of a Democratic win in the US midterm elections.
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
NHPC Reports Q2 Consolidated Net Profit of 15.49 Billion Rupees
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
Pliant Raises $80 Million in Series C Funding
Seaya Nova and Speedinvest led the oversubscribed round. Pliant is opening its commercial payments infrastructure to AI agents.
L impact | EQUITY | Nov 04, 2026, 01:59 PM UTC
Kyndryl Q2 Adjusted Earnings Rise as Revenue Falls; Reaffirms 2026 Outlook
Kyndryl reported higher adjusted earnings and lower revenue for Q2, and reaffirmed its 2026 revenue outlook.
M impact | EQUITY | Nov 04, 2026, 01:59 PM UTC